Works by Takashi Kadowaki


Results: 349
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Cover Image, Volume 24, Issue 12.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 1, doi. 10.1111/dom.14114
    By:
    • Kadowaki, Takashi;
    • Maegawa, Hiroshi;
    • Watada, Hirotaka;
    • Yabe, Daisuke;
    • Node, Koichi;
    • Murohara, Toyoaki;
    • Wada, Jun
    Publication type:
    Article
    12

    Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
    By:
    • Norhammar, Anna;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Haller, Hermann;
    • Linssen, Gerard C. M.;
    • Banerjee, Amitava;
    • Karasik, Avraham;
    • Mamouris, Pavlos;
    • Tangri, Navdeep;
    • Taveira‐Gomes, Tiago;
    • Maggioni, Aldo P.;
    • Botana, Manuel;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Yajima, Toshitaka;
    • Kadowaki, Takashi;
    • Birkeland, Kåre I.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
    By:
    • Espeland, Mark A.;
    • Pratley, Richard E.;
    • Rosenstock, Julio;
    • Kadowaki, Takashi;
    • Seino, Yutaka;
    • Zinman, Bernard;
    • Marx, Nikolaus;
    • McGuire, Darren K.;
    • Andersen, Knut Robert;
    • Mattheus, Michaela;
    • Keller, Annett;
    • Weber, Maria;
    • Johansen, Odd Erik
    Publication type:
    Article
    20

    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Banerjee, Amitava;
    • Kim, Dae Jung;
    • Norhammar, Anna;
    • Eriksson, Jan W.;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Ha, Kyoung Hwa;
    • Kossack, Nils;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    21

    Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Haller, Hermann;
    • Linssen, Gerard C.M.;
    • Banerjee, Amitava;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Garal‐Pantaler, Elena;
    • Overbeek, Jetty;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    22

    Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1062, doi. 10.1111/dom.13995
    By:
    • Cooper, Mark E.;
    • Rosenstock, Julio;
    • Kadowaki, Takashi;
    • Seino, Yutaka;
    • Wanner, Christoph;
    • Schnaidt, Sven;
    • Clark, Douglas;
    • Johansen, Odd Erik
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 453, doi. 10.1111/dom.13079
    By:
    • Kadowaki, Takashi;
    • Inagaki, Nobuya;
    • Kondo, Kazuoki;
    • Nishimura, Kenichi;
    • Kaneko, Genki;
    • Maruyama, Nobuko;
    • Nakanishi, Nobuhiro;
    • Gouda, Maki;
    • Iijima, Hiroaki;
    • Watanabe, Yumi
    Publication type:
    Article
    29
    30
    31

    Alcohol consumption and subclinical and clinical coronary heart disease: a Mendelian randomization analysis.

    Published in:
    European Journal of Preventive Cardiology, 2022, v. 29, n. 15, p. 2006, doi. 10.1093/eurjpc/zwac156
    By:
    • Hisamatsu, Takashi;
    • Miura, Katsuyuki;
    • Tabara, Yasuharu;
    • Sawayama, Yuichi;
    • Kadowaki, Takashi;
    • Kadota, Aya;
    • Torii, Sayuki;
    • Kondo, Keiko;
    • Yano, Yuichiro;
    • Fujiyoshi, Akira;
    • Yamamoto, Takashi;
    • Nakagawa, Yoshihisa;
    • Horie, Minoru;
    • Kimura, Takeshi;
    • Okamura, Tomonori;
    • Ueshima, Hirotsugu;
    • Groups, for the SESSA and ACCESS Research
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia.

    Published in:
    FASEB Journal, 2021, v. 35, n. 12, p. 1, doi. 10.1096/fj.202100882R
    By:
    • Sohta Ishihama;
    • Satoya Yoshida;
    • Tatsuya Yoshida;
    • Yu Mori;
    • Noriyuki Ouchi;
    • Shunsuke Eguchi;
    • Teruhiro Sakaguchi;
    • Takuma Tsuda;
    • Katsuhiro Kato;
    • Yuuki Shimizu;
    • Koji Ohashi;
    • Takahiro Okumura;
    • Bando, Yasuko K.;
    • Hiroaki Yagyu;
    • Nina Wettschureck;
    • Naoto Kubota;
    • Offermanns, Stefan;
    • Takashi Kadowaki;
    • Toyoaki Murohara;
    • Mikito Takefuji
    Publication type:
    Article
    40
    41

    Differences between home blood pressure and strictly measured office blood pressure and their determinants in Japanese men.

    Published in:
    Hypertension Research, 2021, v. 44, n. 1, p. 80, doi. 10.1038/s41440-020-00533-w
    By:
    • Kadowaki, Sayaka;
    • Kadowaki, Takashi;
    • Hozawa, Atsushi;
    • Fujiyoshi, Akira;
    • Hisamatsu, Takashi;
    • Satoh, Atsushi;
    • Arima, Hisatomi;
    • Tanaka, Sachiko;
    • Torii, Sayuki;
    • Kondo, Keiko;
    • Kadota, Aya;
    • Masaki, Kamal;
    • Okamura, Tomonori;
    • Ohkubo, Takayoshi;
    • Miura, Katsuyuki;
    • Ueshima, Hirotsugu
    Publication type:
    Article
    42
    43
    44

    Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1204, doi. 10.1093/ndt/gfac242
    By:
    • Nangaku, Masaomi;
    • Takama, Hirotaka;
    • Ichikawa, Tomohiro;
    • Mukai, Kazuya;
    • Kojima, Masahiro;
    • Suzuki, Yusuke;
    • Watada, Hirotaka;
    • Wada, Takashi;
    • Ueki, Kohjiro;
    • Narita, Ichiei;
    • Kashihara, Naoki;
    • Kadowaki, Takashi;
    • Hase, Hiroki;
    • Akizawa, Tadao
    Publication type:
    Article
    45
    46
    47
    48
    49
    50